| Kallie Jo Wennerberg, AGNP-C | |
|
736 Broadway N, Fargo, ND 58102-4421 | |
| (701) 234-2000 | |
| Not Available |
| Full Name | Kallie Jo Wennerberg |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 736 Broadway N, Fargo, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538893920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | R43359 (North Dakota) | Primary |
| Entity Name | Sanford Medical Center Fargo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184917924 PECOS PAC ID: 8426967803 Enrollment ID: O20110331000495 |
News Archive
Ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor, Weill Cornell Medical College scientists report today. But a therapy that restores the cells' disease-fighting abilities could provide a powerful new strategy to attack the cancer, which kills more than 14,000 women each year.
Athersys, Inc. announced today that the U.S. Food and Drug Administration (FDA) has authorized commencement of a Phase II clinical trial evaluating the safety and efficacy of administration of MultiStem, Athersys' allogeneic investigational cell therapy product, for the potential treatment of ulcerative colitis.
Researchers at the Johns Hopkins Kimmel Cancer Center used machine learning techniques to detect mutational signatures in cancer patients.
Medtronic Foundation and Take Heart Minnesota™ today announced a comprehensive statewide initiative, the first in the nation, designed to increase sudden cardiac arrest (SCA) survival rates. SCA is a condition in which the heart abruptly stops without warning. More than 4,500 cases of SCA were reported in Minnesota in 2008, an average of 12.5 incidences per day.
A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to data presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kallie Jo Wennerberg, AGNP-C Po Box 5074, Sioux Falls, SD 57117-5074 Ph: () - | Kallie Jo Wennerberg, AGNP-C 736 Broadway N, Fargo, ND 58102-4421 Ph: (701) 234-2000 |
News Archive
Ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor, Weill Cornell Medical College scientists report today. But a therapy that restores the cells' disease-fighting abilities could provide a powerful new strategy to attack the cancer, which kills more than 14,000 women each year.
Athersys, Inc. announced today that the U.S. Food and Drug Administration (FDA) has authorized commencement of a Phase II clinical trial evaluating the safety and efficacy of administration of MultiStem, Athersys' allogeneic investigational cell therapy product, for the potential treatment of ulcerative colitis.
Researchers at the Johns Hopkins Kimmel Cancer Center used machine learning techniques to detect mutational signatures in cancer patients.
Medtronic Foundation and Take Heart Minnesota™ today announced a comprehensive statewide initiative, the first in the nation, designed to increase sudden cardiac arrest (SCA) survival rates. SCA is a condition in which the heart abruptly stops without warning. More than 4,500 cases of SCA were reported in Minnesota in 2008, an average of 12.5 incidences per day.
A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to data presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3.
› Verified 1 days ago
Wendy M Moore, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 901 28th St S, Fargo, ND 58103 Phone: 701-404-1100 Fax: 701-540-6498 | |
Mrs. Kayla L. Nelson, DNP, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 301 Np Ave N, Fargo, ND 58102 Phone: 701-271-3344 | |
Kyrie Marie Severson, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4622 40th Ave S, Suite A, Fargo, ND 58104 Phone: 701-364-2909 Fax: 701-364-9822 | |
Sadie Marie Nelson, APRN, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Sanford Broadway Clinic, 801 North Broadway, Fargo, ND 58102 Phone: 701-234-2000 | |
Jessica Smolen, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 321 8th Ave N, Fargo, ND 58102 Phone: 701-234-2525 | |
Mr. Nicholas Henry Frederiksen, APRN,CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3000 32nd Ave S, Fargo, ND 58103 Phone: 701-364-8000 Fax: 701-364-8078 | |
Erin Marie Wilmes Reiniger, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4671 38th St S, Fargo, ND 58104 Phone: 701-404-5100 Fax: 701-499-1166 |